Dendreon Reports Q2 Earnings On July 30Seeking Alpha… Spectrum Pharmaceuticals Inc announced the initiation of a Phase II study evaluating ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use + rituximab in combination with motexafin gadolini…
OncLivePlenary Sunday at ASCOOncLiveBendamustine—an alkylating agent developed at that time—combined with rituximab produced superior outcomes and fewer toxicities than CHOP plus rituximab in patients with indolent and mantle cell lymphomas. Last b…
Spectrum Pharmaceuticals Announces Publication Demonstrating Enhanced …MarketWatch (press release)The data, published in Blood, the journal of the American Society of Hematology, showed that addition of ZEVALIN following fludarabine, cyclophosphamide…
Dr. Dan Peterson – Working to Turn the Tide for ME/CFSProHealthRituximab's soon to be generic status means Roche has no incentive to undertake expensive studies on its effects in CFS, and without those studies there's little hope insurance comp…
Immune Drug Helps With Kidney DisorderRedOrbitBecause the drug rituximab specifically targets immune cells involved in the development and progression of IMN, Piero Ruggenenti, M.D., Giuseppe Remuzzi, M.D., FRCP (from Mario Negri Institute for Pharmaco…
PharmaStarNefropatia membranosa, conferme italiane per rituximabPharmaStarRituximab, un farmaco fino ad oggi utilizzato per la terapia di malattie collegate al sistema immunitario come i linfomi e l'artrite è efficace in una malattia renale di ori…
This Week in the Medical JournalsGenomeWebAlso in Lancet Oncology, a second team of MD Anderson researchers collaborated with researchers from New Jersey and Puerto Rico in a trial of rituximab combined with lenalidomide to treat relapsed or refractory…
Patients With Serious Kidney Disorder Get Help With Immune DrugRedOrbitPatients with a particular kidney immune disorder experienced remission when taking the immune drug rituximab, even when standard therapies had failed. Rituximab was safe and well-t…
Immune drugs helps with kidney disorderCBS42Idiopathic membranous nephropathy (IMN) can eventually lead to kidney failure. Standard therapies for IMN can be toxic and lead to further complications, but a new study has discovered the drug rituximab whic…
Immune drug helps patients with serious kidney disorderEurekAlert (press release)Patients with a particular kidney immune disorder experienced remission when taking the immune drug rituximab, even when standard therapies had failed. Rituximab was safe …